Keybanc analyst Steve Barger maintains Teradyne (NASDAQ:TER) with a Overweight and raises the price target from $149 to $160.
Keybanc Maintains Overweight on Teradyne, Raises Price Target to $160
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.